BA Partners
Overview
BA Partners is an investment firm that participated in the seed funding round of Kryptos Biotechnologies in 2019.
Portfolio Companies
7
Website
bapartners.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MOIN, Inc. | Mar 2022 | Series B | Co-investor |
| BRLab | Jul 2023 | Early Funding | Co-investor |
| Beyond Honeycomb | Jul 2023 | Series A | Co-investor |
| Medility | Jul 2023 | Pre Seed | Co-investor |
| Flarelane | Feb 2024 | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BA Partners based?
Headquarters information for BA Partners is not publicly available.
When was BA Partners founded?
Founding year information for BA Partners is not publicly available.
How many portfolio companies does BA Partners have?
BA Partners has 7 portfolio companies in Caplight's dataset.
What are some companies in BA Partners's portfolio?
Portfolio companies visible on Caplight include MOIN, Inc., BRLab, Beyond Honeycomb, Medility, Flarelane.
What was BA Partners's most recent investment shown here?
BA Partners's most recent investment in this portfolio sample was in Flarelane in 2024.
What sectors does BA Partners focus on?
BA Partners focuses on FinTech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Crypto & Web3.
What company stages does BA Partners focus on?
BA Partners typically invests at the Early stage.